MarketInOut Stock Screener Log In | Sign Up

Genedrive Plc

LSE • Healthcare • Diagnostics & Research • Quote as of 10/27/2026 15:55
Genedrive Plc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeLSE
Market Capitalization17.66 mln
Float746 mln
Earnings Date11/24/2026

Piotroski F-Score

5 / 9
Neutral

Relative Strength

7 / 100
Severely lagging

Pre-Tax Margin

-593%
Severely loss-making

ROE

-392
Deeply negative

Altman Z-Score

-29.55
Deeply distressed

ROA

-187
Deeply negative

Business Description

Genedrive plc is a UK-based company that designs and manufactures portable molecular diagnostic devices used to detect infectious diseases, identify genetic traits, and support clinical decision-making at the point of care. Its key products include a rapid nucleic acid testing system and a range of diagnostic kits covering areas such as antibiotic-induced hearing loss in newborns, COVID-19 detection, and predicting patient response to the blood-thinning drug Clopidogrel. Founded in 2000 and headquartered in Manchester, the company sells its technology to medical, biotechnology, and pharmaceutical customers across the UK, Europe, the United States, and beyond.

Key Fundamentals

EPS-1.00
ROE-392
RPS0.00
ROIC-1,234
ROA-187
EBITDA, mln-5.47
EV / EBITDA-3.24
EV / EBIT-3.21
Revenue, mln0.93
EV / Revenue19.04

Quote Details

Last 1.00
Change -0.03 (-2.91%)
Open 1.03
Volume 2,469,561
Turnover 2,469,561
Average Volume 2,489,848

Financial Ratios

Pre-Tax Profit Margin-593
Current Ratio0.99
Price / Book5.88
Price / Sales5.88

Financial Strength

Altman Z-Score-29.55
Piotroski F-Score 5 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.26% 4 / 100   
1 Month -15.25% 6 / 100   
2 Months -3.85% 28 / 100   
6 Months 11.11% 77 / 100   
1 Year 63.93% 95 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog